Susquehanna International Group, LLP Pacira Bio Sciences, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 12,093 shares of PCRX stock, worth $229,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,093

Previous 10,822 11.74%

Holding current value

$229,525

Previous $309,000 41.1%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $14,870 - $36,172	1,271 Added 11.74%	12,093 $182,000
Q2 2024 Aug 15, 2024	SELL	$25.5 - $31.51 $536,214 - $662,592	-21,028 Reduced 66.02%	10,822 $309,000
Q1 2024 May 07, 2024	BUY	$27.7 - $35.48 $480,872 - $615,932	17,360 Added 119.81%	31,850 $930,000
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $964,338 - $1.26 Million	-36,639 Reduced 71.66%	14,490 $488,000
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $221,509 - $289,449	-7,220 Reduced 12.37%	51,129 $1.57 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $47.5 $453,667 - $596,600	-12,560 Reduced 17.71%	58,349 $2.34 Million
Q1 2023 May 16, 2023	BUY	$35.53 - $43.38 $2.33 Million - $2.85 Million	65,614 Added 1239.17%	70,909 $2.89 Million
Q4 2022 Feb 14, 2023	SELL	$38.19 - $57.45 $448,923 - $675,324	-11,755 Reduced 68.94%	5,295 $204,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $873,642 - $1 Million	17,050 New	17,050 $907,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $285,382 - $363,633	-4,754 Reduced 60.47%	3,108 $237,000
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $186,075 - $241,312	-3,879 Reduced 33.04%	7,862 $473,000
Q2 2021 Aug 11, 2021	BUY	$59.18 - $69.99 $341,527 - $403,912	5,771 Added 96.67%	11,741 $712,000
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $1 Million - $1.33 Million	-16,894 Reduced 73.89%	5,970 $418,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $1.27 Million - $1.66 Million	-25,115 Reduced 52.35%	22,864 $1.37 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $2.18 Million - $2.64 Million	41,897 Added 688.87%	47,979 $2.88 Million
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $1.16 Million - $1.98 Million	-37,817 Reduced 86.15%	6,082 $319,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $518,953 - $926,441	18,273 Added 71.31%	43,899 $1.47 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $152,268 - $192,107	-4,270 Reduced 14.28%	25,626 $976,000
Q2 2019 Aug 16, 2019	BUY	$36.57 - $47.97 $302,580 - $396,903	8,274 Added 38.27%	29,896 $1.3 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $2.33 Million - $3.06 Million	-63,807 Reduced 74.69%	21,622 $940,000
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $1.95 Million - $2.46 Million	47,167 Added 123.27%	85,429 $3.68 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $870,754 - $1.38 Million	26,507 Added 225.5%	38,262 $1.88 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $2.48 Million - $3.59 Million	-90,270 Reduced 88.48%	11,755 $377,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $3.64 Million - $4.03 Million	102,025	102,025 $3.83 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Pacira Bio Sciences, Inc. Transaction History